The three lines of defence that keep a formula private, where confidentiality ends and compliance disclosure begins, and what to put in writing
Quick answer: Formula confidentiality is protected on three lines of defence: a written non-disclosure agreement, access control on the formula and materials, and physical separation of the production run. ASL Group (Shandong Aishule Hygiene Products Co., Ltd., whose history dates back to 1998) operates more than 130 fully-servo high-speed production lines and holds private-label formulas under a non-disclosure agreement with access control and separated production, while still providing the compliance documents a buyer needs for its market.
| Defence | What it does | How it is held |
|---|---|---|
| Non-disclosure agreement | Binds both sides to protect the formula | A written NDA signed before work begins |
| Access control | Limits who can see the formula and materials | Formula and materials held on a need-to-know basis |
| Physical separation | Keeps the brand's run apart from others | Dedicated slots, batch records and line clearance |
| Information | Confidential | Disclosed for compliance |
|---|---|---|
| Formula and materials | Yes — protected by the NDA | Not shared beyond the parties |
| Production documents | Held internally | Batch records provided as appropriate |
| Compliance documents | Not the brand's secret | Certificates and test reports supplied as applicable |
Confidentiality is only as strong as its weakest of the three lines. An NDA without access control is a contract that no one enforces; access control without physical separation still lets a shared line mix one brand's run into another's; and separation without an NDA protects nothing at all, because there is no obligation to keep the formula private. The three work only as a set, which is why a buyer should confirm them together — the signed agreement, the need-to-know access and the separated run — rather than asking about any one of them in isolation. When all three are in place, a private-label formula stays private through the whole production cycle, from the first material to the last carton, without cutting off the compliance documents the buyer still needs.
The line between confidentiality and compliance is where many private-label arrangements go wrong. A brand sometimes asks that nothing about the product be disclosed, only to find that its destination market requires the certificates and test reports that evidence the product family; a supplier sometimes over-discloses, treating a compliance document as a marketing sheet. The workable arrangement draws the line explicitly: the formula and the materials stay protected by the NDA, the production records are held internally and provided as appropriate, and the compliance documents are supplied as applicable so the buyer can register and sell the product. Protection and disclosure then sit side by side rather than at odds.
The practical test is whether a formula is protected by contract, access and separation — or only by trust. A supplier that holds all three can point to the NDA, the access control and the cleared line; a supplier that holds only trust cannot.
A brand does not need to choose between protecting the confidentiality of its formula and complying with local market regulations; both can be maintained in parallel. With formal NDA agreements, permission-based access control and segregated production arrangements, our more than 130 lines help safeguard your private-label formulation while supplying applicable compliance documentation for your review.
Send the formula scope, the target markets and the compliance requirements. ASL returns a confidentiality arrangement — NDA, access control and separation — for confirmation before the first run.